Concepedia

Clint Lincoln

CL

Statistics

Publications

7

Citations

502

H-Index

7

Active since

1995

Affiliations

Human Genome Sciences (United States)(Current)

University of North Carolina at Chapel Hill

Clint Lincoln is an author at Human Genome Sciences (United States) specializing in medicine, oncology, and tumor necrosis factor superfamily.

Publications per year

1995–2005

7

Publications

7

VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas <i>in vivo</i>

Yifan Zhai, Jian Ni, Gongwei Jiang et al. · The FASEB Journal · 1999 · 157 citations

, , +11

Immunohistochemical Analysis of the p16INK4 Cyclin-Dependent Kinase Inhibitor in Malignant Mesothelioma

Robert A. Kratzke, Gregory A. Otterson, Clint Lincoln et al. · JNCI Journal of the National Cancer Institute · 1995 · 125 citations

, , +15

Model development and behavioral assessment of focal cerebral ischemia in rats

David Petullo, Kelly Masonic, Clint Lincoln et al. · Life Sciences · 1999 · 96 citations

, , +16

Wild-type and mutant retinoblastoma protein in paraffin sections.

Joseph Geradts, Robert A. Kratzke, S. Crush-Stanton et al. · PubMed · 1996 · 47 citations

, , +7

Rapid and specific targeting of 125I-labeled B lymphocyte stimulator to lymphoid tissues and B cell tumors in mice.

Todd Riccobene, R. Miceli, Clint Lincoln et al. · PubMed · 2003 · 28 citations

, , +14

1–5 of 7